Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Jul, 7 2025
Oct, 26 2025
Mar, 30 2026
Sep, 4 2023
Jan, 31 2026